Alzheimer's medicines can cause side effects such as nausea, diarrhea, dizziness, headaches, constipation, loss of appetite and sleep problems. Some medicines may also cause more serious problems, including a slow heartbeat, fainting, allergic reactions, or swelling and bleeding in the brain. The possible effects depend on the particular medicine, its dose and the person's overall health.
Several medicines are used to manage Alzheimer's disease. Some help with memory and thinking symptoms, while newer treatments target changes in the brain associated with the disease. Because these medicines work differently, their side effects are not the same.
Which Alzheimer's medicines can cause side effects?
The main medicines used for Alzheimer's disease include cholinesterase inhibitors, memantine and certain newer medicines called anti-amyloid treatments.
Cholinesterase inhibitors include:
- Donepezil: Used to help manage symptoms across different stages of Alzheimer's disease.
- Galantamine: Used to manage symptoms of mild to moderate Alzheimer's disease.
- Rivastigmine: Available as an oral medicine and a skin patch for managing Alzheimer's symptoms.
Memantine is another commonly used medicine, particularly for moderate to severe Alzheimer's disease. Anti-amyloid medicines, including lecanemab and donanemab, are different because they target amyloid proteins in the brain and are intended for selected people in the early stages of the disease.
According to the NHS guidance on Alzheimer's disease treatment, cholinesterase inhibitors and memantine have different side-effect profiles, and the choice of medicine depends partly on the person's circumstances and ability to tolerate treatment.
What are the common side effects of donepezil, rivastigmine and galantamine?
Donepezil, rivastigmine and galantamine belong to the same medicine group. They increase the availability of acetylcholine, a chemical messenger involved in memory and other thinking functions.
Although these medicines can help manage Alzheimer's symptoms, they may affect the digestive system, appetite, sleep and muscles.
Digestive problems
Stomach-related problems are among the most common side effects of cholinesterase inhibitors. They may be more noticeable when treatment begins or when the dose is increased.
Possible digestive side effects include:
- Nausea or an unsettled stomach.
- Vomiting.
- Diarrhea.
- Loss of appetite.
- Weight loss.
These effects can interfere with regular eating and drinking. Persistent vomiting or diarrhea may also contribute to dehydration, particularly in older adults. Ongoing appetite loss or unexpected weight loss should be discussed with the prescribing healthcare professional.
Sleep disturbances and unusual dreams
Some people taking cholinesterase inhibitors experience difficulty sleeping, vivid dreams or nightmares. These effects may affect nighttime rest and contribute to tiredness during the day.
The timing of medication can matter. For example, donepezil taken at night may contribute to unusual or vivid dreams in some people. A healthcare professional can review whether changing the medication schedule is appropriate.
Muscle cramps and urinary problems
Muscle cramps, muscle twitching and changes in bladder control are other possible side effects. Some people experience increased urinary frequency or difficulty controlling urination.
These problems may affect everyday comfort and activities. A change in bladder habits should be discussed with a healthcare professional, particularly when it begins after a medication is started or its dose changes.
The Mayo Clinic's information about Alzheimer's medicines identifies nausea, diarrhea, loss of bladder control, muscle cramps, muscle twitching and weight loss among the possible side effects of cholinesterase inhibitors. It also notes that starting at a lower dose and gradually increasing it may help reduce some unwanted effects.
Can Alzheimer's medicines cause a slow heartbeat or fainting?
Yes. Cholinesterase inhibitors, particularly donepezil, can affect heart rate in some people. A slow heartbeat may cause dizziness, weakness or fainting.
People with certain existing heart rhythm problems may have additional risks when taking these medicines. A healthcare professional should know about any history of an irregular heartbeat, fainting or other heart conditions before prescribing treatment.
Possible warning signs that need urgent medical attention include:
- Unexplained fainting or loss of consciousness.
- A noticeably slow heartbeat accompanied by dizziness or weakness.
- New or worsening chest pain.
- New or worsening breathing difficulties.
- Seizures.
Some cholinesterase inhibitors can also be associated with stomach or intestinal bleeding. Black, tar-like stools, blood in the stool or vomiting blood require urgent medical assessment.
MedlinePlus information about donepezil identifies fainting, a slow heartbeat, chest pain, breathing problems, gastrointestinal bleeding and seizures as serious warning signs that require immediate medical attention.
What are the side effects of memantine?
Memantine works differently from donepezil, rivastigmine and galantamine. It regulates the activity of glutamate, a chemical messenger involved in learning and memory.
It is commonly used for moderate to severe Alzheimer's disease. Although some people tolerate it well, others experience side effects involving the digestive system, balance, alertness or behaviour.
Possible side effects include:
- Dizziness: A feeling of lightheadedness or unsteadiness that may affect walking and everyday activities.
- Headaches: Head pain or discomfort.
- Constipation: Difficulty passing stools or having bowel movements less frequently.
- Confusion: Changes in awareness or difficulty following conversations and activities.
- Sleepiness: Feeling unusually tired or less alert during the day.
- Agitation: Increased restlessness or irritability.
- Hallucinations: Seeing things or hearing sounds or voices that are not actually present.
Some people may also experience nausea, vomiting or diarrhea. The effects can vary, and not everyone taking memantine experiences them.
Hallucinations, significant changes in behaviour or persistent confusion should be reported to a healthcare professional. These experiences may be related to medication, Alzheimer's disease or another health problem, so their timing and circumstances need to be considered.
Do newer Alzheimer's medicines cause brain swelling or bleeding?
Yes. Newer anti-amyloid medicines, including lecanemab (Leqembi) and donanemab (Kisunla), can cause a potentially serious side effect called amyloid-related imaging abnormalities, commonly shortened to ARIA.
ARIA involves changes in the brain that can be seen on magnetic resonance imaging (MRI). There are two main forms:
- ARIA-E: Swelling or fluid accumulation in certain areas of the brain.
- ARIA-H: Small areas of bleeding or blood-related deposits in the brain.
Many people who develop ARIA do not experience noticeable symptoms. However, serious complications can occur, including larger brain bleeds and life-threatening problems.
The official DailyMed prescribing information for lecanemab, maintained by the US National Library of Medicine, includes a prominent warning about ARIA. It explains that brain swelling and bleeding can sometimes cause serious neurological problems.
What symptoms can occur with ARIA?
When ARIA causes symptoms, possible warning signs include:
- New or persistent headaches.
- Confusion or unusual changes in awareness.
- Dizziness or difficulty maintaining balance.
- Changes in vision.
- Nausea.
- Difficulty walking.
- Muscle weakness or numbness.
- Difficulty speaking.
- Seizures.
These symptoms should not be ignored during treatment with an anti-amyloid medicine. Sudden weakness, difficulty speaking, seizures or other new neurological changes require immediate emergency assessment because ARIA can sometimes resemble a stroke.
Can anti-amyloid medicines cause allergic reactions?
Yes. Lecanemab and donanemab can cause reactions associated with receiving the medicine. Some occur during or shortly after an infusion.
Possible infusion-related reactions include:
- Fever or chills.
- Flu-like feelings.
- Headaches.
- Nausea or vomiting.
- Changes in blood pressure.
- Breathing discomfort.
Allergic reactions may also occur. Severe hypersensitivity reactions, including anaphylaxis, are possible with these medicines. Sudden swelling of the face or throat, difficulty breathing or other signs of a severe allergic reaction require emergency medical care.
The official DailyMed prescribing information for donanemab describes ARIA, infusion-related reactions and hypersensitivity reactions, including potentially serious allergic reactions.
Who may have a higher risk of serious side effects?
Not everyone has the same risk of medication-related problems. A person's medical history, existing health conditions, other medicines and the particular Alzheimer's treatment all matter.
Some factors deserve particular attention.
Existing heart conditions
People with certain heart rhythm problems may be more vulnerable to complications involving cholinesterase inhibitors. A history of unexplained fainting or an unusually slow heartbeat should be discussed before starting treatment.
Genetic factors and anti-amyloid treatment
People who have two copies of the APOE ε4 gene variant have a higher risk of developing ARIA while receiving lecanemab or donanemab than people with one or no copies.
Healthcare professionals may discuss APOE genetic testing before treatment to help understand this risk. Testing decisions should include a discussion of what the results mean for the person and their family.
Other medicines and medical conditions
Other prescription medicines, non-prescription products and existing health conditions can influence medication safety. Blood-thinning medicines are particularly important to discuss before anti-amyloid treatment because they may affect the risk of bleeding complications.
People should provide their healthcare professional with a complete list of their medicines, vitamins and supplements. This helps identify possible interactions and situations that may require additional monitoring.
How are the side effects of Alzheimer's medicines managed?
Managing side effects starts with identifying which medicine may be responsible and how the symptoms affect everyday life. Healthcare professionals may review the dose, medication schedule, other medicines and existing medical conditions.
Depending on the problem, possible approaches include:
- Gradual dose increases: Starting treatment at a lower dose and increasing it gradually may help reduce digestive problems associated with cholinesterase inhibitors.
- Medication schedule adjustments: Changing the time a medicine is taken may help with certain sleep-related effects.
- Reviewing other medicines: A doctor or pharmacist may identify medicines that could contribute to side effects or interact with Alzheimer's treatment.
- Changing treatment: When side effects remain troublesome, the prescriber may consider a different medicine or formulation.
- Additional monitoring: People receiving anti-amyloid medicines may need scheduled MRI scans to check for signs of ARIA, even when they feel well.
Some digestive side effects of cholinesterase inhibitors may become less noticeable over time. The NHS notes that these effects often improve after approximately two weeks, although this is not guaranteed for everyone.
For anti-amyloid treatment, MRI monitoring is particularly important because ARIA may develop without obvious symptoms. The monitoring schedule depends on the medicine and the treating team's recommendations.
What should caregivers watch for during Alzheimer's treatment?
Family members and caregivers can play an important role in recognizing medication-related problems. A person with Alzheimer's may find it difficult to explain discomfort, remember when symptoms began or describe changes in their condition.
Observing changes in everyday activities can help the healthcare team assess whether a medicine is being tolerated.
Caregivers can pay attention to:
- Changes in appetite, eating habits or body weight.
- Vomiting, diarrhea or constipation.
- New dizziness, falls or difficulty walking.
- Unusual sleep patterns or daytime sleepiness.
- New confusion, agitation or unusual behaviour.
- Changes in alertness or episodes of fainting.
- New headaches or vision changes during anti-amyloid treatment.
Keeping a simple record of symptoms, medication timing and recent dose changes can make medical reviews more useful. It can also help distinguish a possible medication reaction from changes associated with Alzheimer's disease or another illness.
Caregivers should contact the prescribing healthcare professional when side effects persist, worsen or interfere with eating, sleeping, walking or other daily activities. Emergency symptoms, particularly fainting, seizures, severe allergic reactions or sudden neurological changes, require immediate medical attention.
Should someone stop Alzheimer's medicine because of side effects?
Not necessarily. Experiencing a side effect does not automatically mean that a medicine must be stopped. Some effects may improve with time, while others may require a change in dose, timing or treatment.
Stopping treatment without medical advice may interrupt the intended management of Alzheimer's symptoms. It is important to discuss troublesome effects with the prescribing professional before changing or discontinuing medication.
When deciding whether to continue treatment, healthcare professionals consider the side effects, the person's overall health, the potential benefits of the medicine and its impact on daily life.
The aim is to find an approach that provides an appropriate balance between potential benefits and medication-related risks while supporting the person's comfort and quality of life.